Evaluation of the effectiveness of a chemoprevention model of pancreatic adenocarcinoma using protein chip technology

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1515-1520

  Cao, Liping ^a   Wang, Liang ^a   Wang, Guifeng ^a   Liu, Daren ^a   Yu, Jiekai ^a   Que, Risheng ^a   Xie, Dafei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemoprevention; Gemcitabine; Pancreatic cancer; SELDI TOF MS

Indexed keywords

A 283463; BIOLOGICAL MARKER; GEMCITABINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN MICROARRAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT OUTCOME; XENOGRAFT;

EID: 78649972440     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000804     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Eckel F, Schneider G and Schmid RM: Pancreatic cancer: a review of recent advances. Expert Opin Investig Drugs 15: 1395-1410, 2006. (Pubitemid 44615288)
3. Brambs HJ and Claussen CD: Pancreatic and ampullary carcinoma. Ultrasound, computed tomography, magnetic resonance imaging and angiography. Endoscopy 25: 58-68, 1993.
4. Satake K: Diagnosis of pancreatic cancer. Serological markers. Int J Pancreatol 9: 93-98, 1991.
5. Ali CW, Kaye TF, Adamson DJ, Tait IS, Polignano FM and Highley MS: CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma. J Gastrointest Cancer 38: 108-114, 2007.
6. Philip PA, Zalupski MM, Vaitkevicius VK, Arlauskas P, Chaplen R, Heilbrun LK, Adsay V, Weaver D and Shields AF: Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma. Cancer 92: 569-577, 2001. (Pubitemid 32735192)
7. Heinemann V, Schermuly MM, Stieber P, Schulz L, Jüngst D, Wilkowski R and Schalhorn A: CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin. Anticancer Res 19: 2433-2435, 1999.
8. Stemmler J, Stieber P, Szymala AM, Schalhorn A, Schermuly MM, Wilkowski R, Helmberger T, Lamerz R, Stoffregen C, Niebler K, Garbrecht M and Heinemann V: Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? Onkologie 26: 462-467, 2003.
9. Rai AJ and Chan DW: Cancer proteomics: serum diagnostics for tumor marker discovery. Ann NY Acad Sci 1022: 286-294, 2004.
10. Patel PS, Telang SD, Rawal RM and Shah MH: A review of proteomics in cancer research. Asian Pac J Cancer Prev 6: 113-117, 2005.
11. Wright GL Jr: SELDI ProteinChip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn 2: 549-563, 2002.
12. Weinberger SR, Boschetti E, Santambien P and Brenac V: Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): a new method for rapid development of process chromatography conditions. J Chromatogr B Analyt Technol Biomed Life Sci 782: 307-316, 2002.
13. Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ and Tempst P: Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 4: 1060-1072, 2005.
14. Bhattacharyya S, Siegely ER, Petersen GM, Chari ST, Suva LJ and Haun RS: Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia 6: 674-686, 2004.
15. Liu D, Cao L, Yu J, Que R, Jiang W, Zhou Y and Zhu L: Diagnosis of pancreatic adenocarcinoma using protein chip technology. Pancreatology 9: 127-135, 2009.
16. Liu Y: Active learning with support vector machine applied to gene expression data for cancer classification. J Chem Inf Comput Sci 44: 1936-1941, 2004.
17. Somorjai RL, Dolenko B and Baumgartner R: Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 19: 1484-1491, 2003. (Pubitemid 37045318)
18. Byvatov E and Schneider G: Support vector machine applications in bioinformatics. Appl Bioinformatics 2: 67-77, 2003.
19. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M and Haussler D: Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16: 906-914, 2000.
20. Jorissen RN and Gilson MK: Virtual screening of molecular databases using a support vector machine. J Chem Inf Model 45: 549-561, 2005.